CNGA4 抗体 (AA 128-177)
Quick Overview for CNGA4 抗体 (AA 128-177) (ABIN6753421)
抗原
See all CNGA4 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 128-177
- 
                                            特异性
- Human CNGA4
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide located between aa128-177 of human CNGA4 (Q8IV77-2). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Mouse, Rat, Dog, Bovine, Rabbit, Pig, Guinea pig (100%).
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- Distilled water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized from PBS, 2 % sucrose.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 
                        Short term: 4°C
 Long term: -20°C.
 
- 
                                            
- 
    - CNGA4 (Cyclic Nucleotide Gated Channel alpha 4 (CNGA4))
- 
                                            别名
- CNGA4
- 
                                            背景
- 
                        Name/Gene ID: CNGA4
 Subfamily: Cyclic nucleotide gated channel
 Family: Ion Channel
 Synonyms: CNGA4, CNG2B, Cgn2, CNG channel alpha-4, CNG-4, CNCA2, CNG4, CNG5, OCNC2, OCNCBETA, OCNCb, CNGB2
- 
                                            基因ID
- 1262
 抗原
- 
                    
 
                                     
                                     
                                    